News from PROTEIN SCIENCES CORPORATION A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

22 Jun, 2017, 10:07 ET Superior Protection by Flublok® Influenza Vaccine in Seniors Documented in New England Journal of Medicine

Protein Sciences Corporation announced the publication of clinical trial results comparing Flublok® Quadrivalent – the quadrivalent version...


04 Apr, 2017, 15:56 ET Flublok Quadrivalent Influenza Vaccine Adds a 9 Month Shelf Life to Its List of Benefits

Protein Sciences Corporation, maker of Flublok® Influenza Vaccine, announced that FDA approved an extended shelf life for Flublok Quadrivalent from...


21 Mar, 2017, 11:07 ET Protein Sciences Gears Up to Combat Pandemic Influenza Due to Recent Outbreaks in China

In light of the growing concern over recent Avian Influenza outbreaks in China, Protein Sciences Corporation, maker of the highly effective...


22 Feb, 2017, 10:07 ET Protein Sciences and Partnership for Influenza Vaccine Introduction (PIVI) Team Up to Combat the Flu in Mongolia

Protein Sciences Corporation, a leading vaccine development company and maker of Flublok® Influenza Vaccine, announced today that they donated...


12 Jan, 2017, 10:17 ET Protein Sciences Zika Vaccine Shows Good Results in Preclinical Testing

Protein Sciences Corporation, a leading vaccine development company and maker of Flublok Influenza Vaccine®, announced today that its lead protein...


26 Oct, 2016, 11:07 ET Flublok® Influenza Vaccine Now Available in Mexico

Mexico welcomed the availability of Flublok last Thursday with the official launch of Flublok influenza vaccine in Mexico City. Mexican regulatory...


20 Oct, 2016, 12:07 ET Protein Sciences Launches Social Media Campaign for Flublok® Influenza Vaccine to Raise Money for Health-based Charities

Protein Sciences Corporation proudly announced the launch of a new social media campaign - #ShowMeTheVial - featuring Flublok® influenza vaccine...


11 Oct, 2016, 13:15 ET FDA Approves Flublok® Quadrivalent Influenza Vaccine

Protein Sciences Corporation announced today that the FDA has approved its quadrivalent formulation of Flublok® influenza vaccine. Flublok...


22 Sep, 2016, 10:07 ET Protein Sciences and Avanzcare Announce Licensing of Influenza Vaccines for the MENA Region

Protein Sciences Corporation (headquarters: Meriden, CT, USA) and Avanzcare, the medical arm of Al Sawari Holding (headquarters: Doha, Qatar)...


07 Sep, 2016, 10:07 ET U.S. Biomedical Advanced Research and Development Authority (BARDA) Awards Protein Sciences Multi-Million Dollar Contract for Pandemic Preparedness

Protein Sciences Corporation announced today that the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S....


10 Aug, 2016, 10:47 ET First Doses of Flublok® Influenza Vaccine of 2016/17 Have Shipped

Protein Sciences Corporation announced that the FDA has approved and released the first lots of Flublok® influenza vaccine for distribution...


12 Jul, 2016, 10:07 ET 2016/17 Formulation of Flublok® Influenza Vaccine Receives FDA Approval

Protein Sciences Corporation announced that FDA has approved the 2016/17 formulation of Flublok® influenza vaccine.   Unlike...


30 Jun, 2016, 10:36 ET Flublok® Influenza Vaccine is a great alternative for FluMist for adults 18 and older

 On Wednesday, the CDC's Advisory Committee on Immunization Practices (ACIP) recommended against the use of live attenuated influenza vaccine...


29 Jun, 2016, 10:07 ET UMN Pharma Joins Protein Sciences' International Zika Vaccine Consortium

USA and Japan -- Protein Sciences Corporation, manufacturer of Flublok® influenza vaccine, and UMN Pharma Inc. (Akita, Akita prefecture,...


28 Jun, 2016, 10:07 ET Protein Sciences Announces Exclusive License to uniQure of Cell Line and Technology for Production of Human Gene Therapies

Protein Sciences Corporation, makers of Flublok® influenza vaccine, announced today that they have entered into an agreement with uniQure NV,...


23 Jun, 2016, 11:15 ET FDA Approved Longer Shelf Life for the Game Changer, Flublok® Influenza Vaccine

Protein Sciences Corporation announced today that FDA has extended the shelf life for Flublok, its game changing seasonal influenza vaccine, to 9...


12 Feb, 2016, 09:29 ET Protein Sciences and UNIGEN Reach Agreement to Source Flublok® Influenza Vaccine from Japan

 Protein Sciences Corporation (Meriden, CT and Pearl River, NY) and UMN Pharma Inc. (Akita, Akita prefecture, Japan) announced today that...


18 Nov, 2015, 10:52 ET Flublok® Influenza Vaccine Approved in Mexico

Protein Sciences Corporation, manufacturer of Flublok®, is pleased to announce that Laboratorios Liomont, S.A. de C.V. (Liomont), a leading...


12 Nov, 2015, 10:07 ET Protein Sciences Awarded a Small Business Innovation Research Grant for the Development of a Novel Adenovirus Vaccine

 Protein Sciences Corporation, makers of Flublok® Influenza Vaccine, announced today that they have been awarded a Phase I Small...


29 Oct, 2015, 11:55 ET Protein Sciences President and CEO Manon Cox Elected as 2015 Fellow of the International Society for Vaccines

Protein Sciences Corporation, the makers of Flublok®Influenza Vaccine, announced today that Dr. Manon Cox, President and CEO, was elected as a...


13 May, 2015, 12:24 ET Protein Sciences New York Facility Receives FDA Licensure to Manufacture Flublok®

Protein Sciences Corporation announced that on May 12, 2015 the U.S. Food and Drug Administration (FDA) licensed its Pearl River, NY manufacturing...


29 Jan, 2015, 10:06 ET Clinical Efficacy Study of Flublok® Quadrivalent Compares Flublok to a Traditional Egg-based Flu Vaccine

 Protein Sciences Corporation announced today that results from a double-blinded comparative efficacy study of Flublok Quadrivalent in adults...


22 Dec, 2014, 10:01 ET Protein Sciences, UMN Pharma and IHI Corporation Enter into an Agreement to Evaluate Sourcing Flublok® from Japan

Protein Sciences Corporation (Meriden, CT and Pearl River, NY), UMN Pharma Inc. (Akita, Akita prefecture, Japan) and IHI Corporation (Koto-ku,...


29 Oct, 2014, 16:44 ET Flublok® Influenza Vaccine Now Approved for Adults Ages 18 and Older

Protein Sciences Corporation announced today that the U.S. FDA has approved Flublok influenza vaccine for all adults aged 18 years and older,...


29 Sep, 2014, 10:07 ET Flublok® Influenza Vaccine Now Available for the 2014/2015 Influenza Season

 Protein Sciences Corporation, manufacturer of the revolutionary Flublok influenza vaccine, announced today that doses of the vaccine have been...